Ligand Pharmaceuticals (Nasdaq: LGND) completed its acquisition of XOMA Royalty Corporation on July 14, 2026, paying $39.00 per share in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE